Ziekenhuis Nij Smellinghe

At Ziekenhuis Nij Smellinghe, research in cardiovascular diseases and related health care quality topics focuses on improving outcomes for people with severe chronic kidney disease and heart-related complications. The studies are designed to evaluate whether new treatment strategies can reduce major events such as kidney failure, hospitalization for heart failure, and death.

• Testing a therapy aimed at lowering the risk of kidney and heart complications in patients with advanced kidney disease
• Studying combined clinical outcomes to better understand treatment benefit in high-risk patient groups
• Generating evidence to support better care for patients with overlapping kidney and cardiovascular conditions

This work reflects a strong interest in treatment effectiveness and long-term patient outcomes across complex internal medicine conditions.

Clinical research in male urogenital diseases and neoplasms includes studies in metastatic castration-resistant prostate cancer, with a clear goal of improving disease control and extending progression-free survival. The site is also involved in broader cancer research that explores new options for patients with advanced solid tumors.

• Evaluating new treatment combinations for advanced prostate cancer
• Assessing whether targeted cancer therapies can improve outcomes in difficult-to-treat tumors
• Supporting access to promising oncology treatments for patients with limited options

These studies aim to refine cancer treatment and better match therapy to patient needs in advanced disease.

The breast cancer portfolio at this hospital covers both early and metastatic disease, with studies in HER2-positive breast cancer, triple negative breast cancer, and hormone receptor-positive metastatic breast cancer. The research is focused on testing better treatment strategies, including approaches that may reduce unnecessary chemotherapy while preserving effectiveness.

• Improving treatment for HER2-positive breast cancer
• Evaluating new approaches for triple negative breast cancer after initial therapy
• Comparing endocrine-based strategies for advanced hormone receptor-positive disease

Overall, these trials seek to make breast cancer care more precise, effective, and better tailored to disease subtype.

Research in hematologic cancers includes multiple myeloma, non-Hodgkin lymphoma, and T-cell prolymphocytic leukemia. The studies examine whether targeted and immune-based cancer treatments can improve response, control disease progression, and expand access to promising options for patients with blood cancers.

• Studying treatment effectiveness in multiple myeloma and lymphoma
• Exploring targeted therapies for genetically defined blood cancers
• Assessing safety and anti-tumor activity of new oncology approaches

This area highlights a strong focus on personalized cancer care in difficult-to-treat hematologic diseases.

The site also conducts broader internal medicine research in areas such as acute critical illness and gestational diabetes mellitus. These studies are designed to improve everyday care, support better decision-making in the intensive care unit, and evaluate whether treatment strategies can improve outcomes for both mothers and children.

• Assessing interventions for adults admitted to intensive care
• Studying ways to improve management of gestational diabetes during and after pregnancy
• Supporting evidence-based care in common hospital and clinic settings

This research shows a practical focus on patient-centered care across acute, metabolic, and maternal health conditions.